Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Treasury Shares: 2023-2025

Historic Treasury Shares for InMed Pharmaceuticals (INM) over the last 3 years, with Jun 2025 value amounting to $4.5 million.

  • InMed Pharmaceuticals' Treasury Shares rose 673.00% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 673.00%. This contributed to the annual value of $4.5 million for FY2025, which is 734.35% up from last year.
  • According to the latest figures from FY2025, InMed Pharmaceuticals' Treasury Shares is $4.5 million, which was up 734.35% from $544,280 recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Treasury Shares registered a high of $4.5 million during FY2025, and its lowest value of $175,802 during FY2023.
  • Moreover, its 3-year median value for Treasury Shares was $544,280 (2024), whereas its average is $1.8 million.
  • Data for InMed Pharmaceuticals' Treasury Shares shows a peak YoY spiked of 734.35% (in 2025) over the last 5 years.
  • Over the past 3 years, InMed Pharmaceuticals' Treasury Shares (Yearly) stood at $175,802 in 2023, then soared by 209.60% to $544,280 in 2024, then surged by 734.35% to $4.5 million in 2025.